SE405254B - Sett att framstella 7-hydroxi-ostratriener - Google Patents

Sett att framstella 7-hydroxi-ostratriener

Info

Publication number
SE405254B
SE405254B SE7511438A SE7511438A SE405254B SE 405254 B SE405254 B SE 405254B SE 7511438 A SE7511438 A SE 7511438A SE 7511438 A SE7511438 A SE 7511438A SE 405254 B SE405254 B SE 405254B
Authority
SE
Sweden
Prior art keywords
ostratriens
hydroxy
preparing
Prior art date
Application number
SE7511438A
Other languages
English (en)
Swedish (sv)
Other versions
SE7511438L (sv
Inventor
K Petzoldt
H-J Vidic
K Prezewowsky
Y Nishino
R Wiechert
H Laurent
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2449327A external-priority patent/DE2449327C2/de
Priority claimed from DE19752535997 external-priority patent/DE2535997A1/de
Application filed by Schering Ag filed Critical Schering Ag
Publication of SE7511438L publication Critical patent/SE7511438L/xx
Publication of SE405254B publication Critical patent/SE405254B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J31/00Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051Estrane derivatives
    • C07J1/0059Estrane derivatives substituted in position 17 by a keto group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051Estrane derivatives
    • C07J1/0081Substituted in position 17 alfa and 17 beta
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051Estrane derivatives
    • C07J1/0081Substituted in position 17 alfa and 17 beta
    • C07J1/0088Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0096Alkynyl derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J17/00Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/911Microorganisms using fungi
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/911Microorganisms using fungi
    • Y10S435/912Absidia
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/911Microorganisms using fungi
    • Y10S435/913Aspergillus
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/911Microorganisms using fungi
    • Y10S435/939Rhizopus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SE7511438A 1974-10-14 1975-10-13 Sett att framstella 7-hydroxi-ostratriener SE405254B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2449327A DE2449327C2 (de) 1974-10-14 1974-10-14 7 α-Hydroxy-östradiole, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE19752535997 DE2535997A1 (de) 1975-08-08 1975-08-08 7-hydroxy-oestradiole

Publications (2)

Publication Number Publication Date
SE7511438L SE7511438L (sv) 1976-04-15
SE405254B true SE405254B (sv) 1978-11-27

Family

ID=25767825

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7511438A SE405254B (sv) 1974-10-14 1975-10-13 Sett att framstella 7-hydroxi-ostratriener

Country Status (23)

Country Link
US (1) US4011314A (US20110232667A1-20110929-C00004.png)
JP (1) JPS5165747A (US20110232667A1-20110929-C00004.png)
AT (1) AT348695B (US20110232667A1-20110929-C00004.png)
CA (1) CA1054143A (US20110232667A1-20110929-C00004.png)
CH (2) CH619240A5 (US20110232667A1-20110929-C00004.png)
CS (2) CS205010B2 (US20110232667A1-20110929-C00004.png)
DD (1) DD125588A5 (US20110232667A1-20110929-C00004.png)
DK (1) DK135378C (US20110232667A1-20110929-C00004.png)
ES (1) ES441784A1 (US20110232667A1-20110929-C00004.png)
FI (1) FI54603C (US20110232667A1-20110929-C00004.png)
FR (1) FR2287908A1 (US20110232667A1-20110929-C00004.png)
GB (1) GB1528796A (US20110232667A1-20110929-C00004.png)
HU (1) HU176715B (US20110232667A1-20110929-C00004.png)
IE (1) IE42167B1 (US20110232667A1-20110929-C00004.png)
IL (1) IL48276A (US20110232667A1-20110929-C00004.png)
NL (1) NL7512041A (US20110232667A1-20110929-C00004.png)
NO (1) NO140824C (US20110232667A1-20110929-C00004.png)
NZ (1) NZ178886A (US20110232667A1-20110929-C00004.png)
PH (1) PH13802A (US20110232667A1-20110929-C00004.png)
PL (2) PL103989B1 (US20110232667A1-20110929-C00004.png)
SE (1) SE405254B (US20110232667A1-20110929-C00004.png)
SU (2) SU676170A3 (US20110232667A1-20110929-C00004.png)
YU (2) YU243975A (US20110232667A1-20110929-C00004.png)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8327256D0 (en) * 1983-10-12 1983-11-16 Ici Plc Steroid derivatives
DE3741800A1 (de) * 1987-12-07 1989-06-15 Schering Ag 17-halogenmethylen-estratriene
US5861431A (en) * 1995-06-07 1999-01-19 Iotek, Inc. Incontinence treatment
CA2250874A1 (en) 1996-04-09 1997-10-16 Btg International Limited Use of 7 alpha-substituted steroids to treat neuropsychiatric, immune or endocrine disorders
EP1832598A3 (en) 1999-09-30 2008-01-02 Hollis-Eden Pharmaceuticals Inc. Therapeutic treatment of androgen receptor driven conditions
GB0003524D0 (en) * 2000-02-15 2000-04-05 Btg Int Ltd Cytoprotective steroids (II)
GB2363983A (en) * 2000-06-29 2002-01-16 Hunter Fleming Ltd Protection against neuronal damage using 7-hydroxyepiandrosterone
ATE340580T1 (de) * 2003-05-22 2006-10-15 Pantarhei Bioscience Bv Verwendung von zusammensetzungen enthaltend ein oestrogen zur behandlung und verhinderung von muskelskelettschmerzen
GB0403889D0 (en) * 2004-02-21 2004-03-24 Univ Edinburgh Uses of er-beta modulators
US7910755B2 (en) 2004-09-29 2011-03-22 Harbor Biosciences, Inc. Stem cell expansion and uses

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3115444A (en) * 1962-01-22 1963-12-24 Olin Mathieson Process for microbial hydroxylation of steroids containing aromatic alpha-rings

Also Published As

Publication number Publication date
US4011314A (en) 1977-03-08
IL48276A (en) 1979-03-12
NO140824C (no) 1979-11-21
IE42167L (en) 1976-04-14
DK135378C (da) 1977-10-03
SE7511438L (sv) 1976-04-15
PL103989B1 (pl) 1979-07-31
DK439975A (da) 1976-04-15
CS205010B2 (en) 1981-04-30
IE42167B1 (en) 1980-06-18
YU294281A (en) 1982-06-30
FR2287908B1 (US20110232667A1-20110929-C00004.png) 1980-04-30
NL7512041A (nl) 1976-04-20
FI752836A (US20110232667A1-20110929-C00004.png) 1976-04-15
FI54603B (fi) 1978-09-29
SU677666A3 (en) 1981-11-30
HU176715B (en) 1981-04-28
AT348695B (de) 1979-02-26
NZ178886A (en) 1978-04-28
CH619268A5 (US20110232667A1-20110929-C00004.png) 1980-09-15
IL48276A0 (en) 1975-12-31
PL101461B1 (pl) 1978-12-30
FI54603C (fi) 1979-01-10
FR2287908A1 (fr) 1976-05-14
CS205009B2 (en) 1981-04-30
SU677666A1 (ru) 1981-11-30
CH619240A5 (US20110232667A1-20110929-C00004.png) 1980-09-15
AU8571075A (en) 1977-04-21
YU243975A (en) 1982-06-30
PH13802A (en) 1980-10-01
ATA775475A (de) 1978-07-15
ES441784A1 (es) 1977-04-01
SU676170A3 (ru) 1979-07-25
JPS5165747A (en) 1976-06-07
CA1054143A (en) 1979-05-08
NO753455L (US20110232667A1-20110929-C00004.png) 1976-04-20
GB1528796A (en) 1978-10-18
DK135378B (da) 1977-04-18
DD125588A5 (US20110232667A1-20110929-C00004.png) 1977-05-04
NO140824B (no) 1979-08-13

Similar Documents

Publication Publication Date Title
SE423633B (sv) Forfarande for framstellning av 4-demetoxi-daunomycin
SE404804B (sv) Sett att framstella 18-metyl-19-nor-20-ketopregnaner
SE431211B (sv) Forfarande for framstellning av n-acylamino-alfa-arylacetamido-cefalosporiner
SE405254B (sv) Sett att framstella 7-hydroxi-ostratriener
SE421612B (sv) Forfarande for framstellning av alfa-6-deoxi-5-hydroxitetracyklin
SE404528B (sv) Sett att framstella 1alfa-hydroxisteroider
SE418292B (sv) Forfarande for framstellning av 5-aryl-2-furamidiner
SE404360B (sv) Sett att framstella 2-nitrobensaldehyd
SE7509126L (sv) Sett att framstella 1-substituerade 2-metyl-tetrahydropyrimidiner.
SE7607239L (sv) Sett att framstella beta-acylpyrroler
SE414926B (sv) Forfarande for framstellning av 1-alkyl-2-(fenoximetyl)-5-nitroimidazoler
SE403373B (sv) Sett att framstella aminosubstituerade tetracykliska foreningar
SE401187B (sv) Sett att framstella deltaŸ4-3-ketosteroid-17-propiolakton
SE402458B (sv) Sett att framstella nya 2-amino-6-dialkylamino-dihydropyridiner
SE411447B (sv) Sett att framstella 4-cyklopropylmetylenoxi- 3-klorfenylettiksyra
IT1033359B (it) Procedimento per produrre alchilfenoli
SE7506388L (sv) Sett att framstella (dl)-13-substituerade sulfinyl-protaglandein-liknande foreningar
SE7508561L (sv) Sett att framstella alfa-azidobensylpenicillin
SE421310B (sv) Forfarande for framstellning av substituerade bensoylpyridiner
SE7613122L (sv) Sett att framstella 4-klor-2-butynyl-m-klorkarbanilat
SU538660A3 (ru) Способ получени -трет.-бутиламинометил4-окси- -ксилол- -диола
SE7605131L (sv) Sett att framstella 3-acyloximetyl-cefemforeningar
SE387111B (sv) Sett att framstella bensoylfenylguanidiner
SE7511324L (sv) Sett att framstella 2-halogenmetyl-1,4-bensodiazepiner
SE407410B (sv) Sett att framstella 3-oxo-17beta-n-amyloxi-ostra-4,9,11-trien